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Xiucui Ma,a,c Haiyan Liu,a,c John T. Murphy,a Sarah R. Foyil,a,c Rebecca J. Godar,a,c Haedar Abuirqeba,a Carla J. Weinheimer,a
Philip M. Barger,a Abhinav Diwana,b,c
Division of Cardiology and Center for Cardiovascular Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USAa;
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USAb; John Cochran VA Medical Center, St. Louis, Missouri,
USAc
In cardiac ischemia-reperfusion injury, reactive oxygen species (ROS) generation and upregulation of the hypoxia-induc-
ible protein BNIP3 result in mitochondrial permeabilization, but impairment in autophagic removal of damaged mito-
chondria provokes programmed cardiomyocyte death. BNIP3 expression and ROS generation result in upregulation of
beclin-1, a protein associated with transcriptional suppression of autophagy-lysosome proteins and reduced activation of
transcription factor EB (TFEB), a master regulator of the autophagy-lysosome machinery. Partial beclin-1 knockdown
transcriptionally stimulates lysosome biogenesis and autophagy via mTOR inhibition and activation of TFEB, enhancing
removal of depolarized mitochondria. TFEB activation concomitantly stimulates mitochondrial biogenesis via PGC1 in-
duction to restore normally polarized mitochondria and attenuate BNIP3- and hypoxia-reoxygenation-induced cell death.
Conversely, overexpression of beclin-1 activates mTOR to inhibit TFEB, resulting in declines in lysosome numbers and
suppression of PGC1 transcription. Importantly, knockdown of endogenous TFEB or PGC1 results in a complete or
partial loss, respectively, of the cytoprotective effects of partial beclin-1 knockdown, indicating a critical role for both mi-
tochondrial autophagy and biogenesis in ensuring cellular viability. These studies uncover a transcriptional feedback loop
for beclin-1-mediated regulation of TFEB activation and implicate a central role for TFEB in coordinating mitochondrial
autophagy with biogenesis to restore normally polarized mitochondria and prevent ischemia-reperfusion-induced cardio-
myocyte death.
Preservation of healthy mitochondria is essential for energygeneration and maintenance of contractile function in car-
diac myocytes (1). In cardiac ischemia-reperfusion (IR) injury,
mitochondrial permeabilization results in activation of pro-
grammed cell death pathways and cardiomyocyte loss (2).
Removal of damaged mitochondria by macroautophagy, a
lysosomal degradative pathway, is essential to prevent cardiomy-
ocyte death and limit myocardial infarct size (3, 4). Cardiomyo-
cyte autophagy is upregulated with IR injury (5), but autophago-
some processing is impaired early after reperfusion, which
prevents autophagic removal of damaged mitochondria (6). The
hypoxic insult also provokes transcriptional induction of BNIP3
(Bcl2 and nineteen-kilodalton interacting protein 3), a prodeath
Bcl2 family protein (7, 8) which is targeted to and permeabilizes
mitochondria (9–11) and triggers cardiomyocyte death in IR in-
jury (12). While BNIP3 has been suggested to facilitate mitochon-
drial autophagy by functioning as an adaptor to sequester dam-
aged mitochondria within autophagosomes (13, 14), increased
BNIP3 expression provokes declines in lysosome numbers, with
impaired autophagic flux, resulting in accumulation of damaged
mitochondria and cardiomyocyte death (15). These observations
implicate a failure of the autophagy-lysosome machinery to clear
damaged mitochondria as a cause of cell death with IR injury, but
the underlying mechanisms remain to be defined.
Mitochondria are also targeted for degradation by starva-
tion, wherein autophagy is critical for cell survival (16, 17).
Interestingly, with starvation, lysosome numbers rapidly plum-
met (18), but endogenous mechanisms are promptly recruited
to drive reformation of new lysosomes (18–20). This is facili-
tated via a transcriptional induction of autophagy-lysosome
machinery proteins orchestrated by nuclear translocation of
the basic helix-loop-helix (bHLH) transcription factor EB
(TFEB) (21–25), a master inducer of the autophagy-lysosome
machinery (23), thereby sustaining autophagic flux. In con-
trast, lysosome numbers progressively decline with BNIP3-in-
duced autophagy, without replenishment (15), suggesting that
an impairment in this transcriptional response engenders “in-
sufficient” cytoprotective autophagy.
Relevant to this discussion is our observation that upon
reperfusion/reoxygenation, a rapid reactive oxygen species
(ROS)-induced increase in beclin-1 abundance paradoxically
impairs autophagic flux in cardiomyocytes (6). Interestingly,
while basal beclin-1 levels play critical roles in autophagosome
Received 25 August 2014 Returned for modification 15 September 2014
Accepted 30 December 2014
Accepted manuscript posted online 5 January 2015
Citation Ma X, Liu H, Murphy JT, Foyil SR, Godar RJ, Abuirqeba H, Weinheimer CJ,
Barger PM, Diwan A. 2015. Regulation of the transcription factor EB-PGC1 axis by
beclin-1 controls mitochondrial quality and cardiomyocyte death under stress.
Mol Cell Biol 35:956–976. doi:10.1128/MCB.01091-14.
Address correspondence to Abhinav Diwan, adiwan@dom.wustl.edu.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
doi:10.1128/MCB.01091-14
956 mcb.asm.org March 2015 Volume 35 Number 6Molecular and Cellular Biology
formation (26) and protection against cardiomyocyte death (6), we
observed that increased beclin-1 abundance is sufficient to suppress
transcription of autophagy-lysosome machinery genes (6). Taken
together with the in vivo observation that haploinsufficiency of
beclin-1 by targeted disruption of a BECN1 allele confers cytopro-
tection in cardiac IR injury (5), these data suggest the hypothesis
that ROS-induced upregulation of beclin-1 transcriptionally im-
pairs the lysosomal machinery to prevent removal of damaged
mitochondria and cause cell death with BNIP3 expression and
hypoxia-reoxygenation injury. In this study, we uncovered an au-
toregulatory loop whereby beclin-1 levels regulate TFEB activity,
which coordinates mitochondrial autophagy with biogenesis to
control mitochondrial quality and regulate stress-induced cardi-
omyocyte death.
MATERIALS AND METHODS
In vivo ischemia-reperfusion modeling. BECN1 heterozygous null mice
(BECN1/; mice with haploinsufficiency of beclin-1) (26) and wild-
type (WT) mice of the C57BL/6 strain were obtained from Jackson
Laboratories and subjected to reversible left anterior descending
(LAD) coronary artery occlusion to induce ischemia for 30 min, fol-
lowed by 4 h of reperfusion, as described previously (6). Briefly, mice
were anesthetized with a mixture of ketamine (80 mg/kg of body
weight) and xylazine (5 mg/kg), surgically prepped, and ventilated.
After thoracotomy, the LAD artery was identified, and a 9-0 polypro-
pylene suture was passed under the LAD artery. A knot was tied over a
1-mm section of PE-10 tubing placed directly over the vessel to create
the occlusion. Ischemia was confirmed by an absence of blood flow,
verified visually, and by the presence of ST elevations on electrocar-
diogram (EKG). Reperfusion was induced to release the occlusion,
which was confirmed by resolution of ST segment elevation. At sacri-
fice, the ventricles were sectioned into three pieces; the apical 1/3 was
subjected to biochemical analysis as the “injured” region, and the basal
1/3 was processed as the “remote” region. Sham-treated mice under-
went the entire surgical procedure without occlusion of the LAD ar-
tery. Autophagic flux was assessed in comparison to that of mice
pretreated with chloroquine (CQ; 40 mg/kg, administered intraperi-
toneally [i.p.]) 30 min prior to IR modeling, as previously described (6,
27). All animal studies were approved by the Animal Studies Commit-
tee at the Washington University School of Medicine and the Institu-
tional Animal Care and Use Committee at the John Cochran VA Med-
ical Center.
Cell culture. Isolation of neonatal rat cardiac myocytes (NRCMs)
was performed as described previously (6). Hearts were removed from
1-day-old Sprague-Dawley rats, the atria and great vessels were
trimmed off, and tissue was finely minced, followed by sequential di-
gestion with 0.5 mg/ml collagenase (Worthington Biochemical, NJ).
Ventricular cardiomyocytes were separated from fibroblasts by differ-
ential plating in medium containing Dulbecco’s modified Eagle’s me-
dium (DMEM), 10% horse serum, 5% fetal calf serum, 100 mol/liter
bromodeoxyuridine, penicillin, streptomycin, and L-glutamine, fol-
lowed by tissue culture in gelatin-coated plates in medium containing
modified DMEM, 100 M bromodeoxyuridine, penicillin, streptomy-
cin, L-glutamine, 10 ng/ml insulin, 10 g/ml transferrin, and 0.5
mg/ml bovine serum albumin.
Nutrient deprivation was induced by culture in serum-free Hanks
balanced salt solution (HBSS; Invitrogen). HEK293 cells were cultured as
described previously (15).
Hypoxia modeling. Cells were subjected to hypoxia in vitro in an
oxygen control cabinet (Coy Laboratories, Grass Lake, MI) mounted
within an incubator and equipped with an oxygen sensor for continuous
oxygen level monitoring. A mixture of 95% nitrogen and 5% CO2 was
infused to create hypoxia, and oxygen levels in the chamber were moni-
tored and maintained at1%, as described previously (6).
Generation of adenoviral constructs. Lentiviral particles coding for
mCherry-GFP-LC3 expression have been described (6). Adenoviral
delivery of constructs was employed to achieve a high efficiency of
transduction and permit evaluation of dose-dependent effects in pri-
mary NRCMs, as previously described (6, 15). Adenoviral particles for
expression of short hairpin RNAs (shRNAs) targeting rat TFEB,
BECN1, and PPARGC1were generated with the BLOCKiT adenoviral
system (Invitrogen). Specific oligonucleotide sequences employed
were as follows (with targeted coding sequences underlined): (i)




oligonucleotide); (ii) shRNA targeting BECN1 (annotated shBECN1-2),
5=-CACCGCTCAGTACCAGCGAGAATATCGAAATATTCTCGCTGG
TACTGAGC-3= (top-strand oligonucleotide) and 5=-AAAAGCT
CAGTACCAGCGAGAATATTTCGATATTCTCGCTGGTACTGA
GC-3= (bottom-strand oligonucleotide); and (iii) shRNA targeting rat
PPARGC1, 5=-CACCGAGCAAGTATGACTCTCTGCGAACAGAGAG
TCATACTTGCTC-3= (top-strand oligonucleotide) and 5=-
AAAAGAGCAAGTATGACTCTCTGTTCGCAGAGAGTCAT
ACTTGCTC-3= (bottom-strand oligonucleotide).
Adenoviral particles for shRNAs targeting BECN1 (annotated
shBECN1-1) (5) and LacZ, as a nontargeting control for studies with
shRNA-mediated knockdown, and for overexpression of LacZ (as a con-
trol), green fluorescent protein (GFP)-tagged LC3, FLAG-hBNIP3,
mBECLIN-1, and hemagglutinin (HA)-tagged hTFEB have been de-
scribed previously (15). Adenoviral particles for expression of FLAG-
PPARGC1 were engineered with a tagging coding sequence for human
PPARGC1 with a FLAG tag at the N terminus, using Gateway cloning
technology (Invitrogen). Viral particles were generated per the manufac-
turer’s instructions. In all experiments, control adenoviral particles were
added to groups as necessary to ensure equal viral particle doses, i.e.,
multiplicities of infection (MOIs), between groups.
Assessment of cell death. Cell death assays were performed in 96-well
plates (Nunc, Fisher) with a Live-Dead cytotoxicity viability kit for mam-
malian cells (Invitrogen), using a Tecan Infinite M200 Pro microplate
reader (Tecan) following the manufacturer’s instructions, as described
previously (6).
Assessment of TUNEL positivity. Terminal deoxynucleotidyltrans-
ferase-mediated dUTP-biotin nick end labeling (TUNEL) was performed
on fixed and permeabilized NRCMs by using the Dead-End fluorometric
TUNEL system (Promega) following the manufacturer’s directions, as
previously described (15).
Cellular ATP content analysis. NRCMs were transduced with adeno-
viral particles for 24 h and then trypsinized, and 5 104 cells were plated
in each well of a 96-well plate. Cellular ATP levels were quantified using a
luciferase reaction-based assay kit (CellTiter-Glo reagent; Promega), and
readings were normalized to those of viable cells assessed by the trypan
blue exclusion method as previously described (28).
Immunofluorescence imaging. Imaging for mCherry-GFP-LC3 and
LysoTracker Red was performed with live NRCMs, and imaging for GFP-
LC3, LAMP1, and TFEB (with immunofluorescence of the HA tag) was
performed with NRCMs fixed with 4% paraformaldehyde (20 min) and
then permeabilized with 0.1% Triton X-100 (5 min), using an Axioscap
upright microscope fitted with an AxioCam HRC camera and Plan Neo-
fluar objectives (20 [numerical aperture {NA}  0.60], 40 [NA 
0.75], and 63 [oil] [NA  1.25] [Zeiss]), along with appropriate filter
cubes, as previously described (6). Nuclear localization of TFEB was as-
sessed in 60 cells/group. LAMP1-positive puncta in 50 cells/group were
counted using ImageJ software as described previously (15), and results
are expressed as numbers of dots/nucleus. Imaging for BNIP3 and
COX-IV was performed on fixed and permeabilized NRCMs with a Zeiss
confocal LSM 700 laser scanning confocal microscope using 63 Zeiss
Plan-Neofluar 40/1.3 and 63/1.4 oil immersion objectives. Nuclei
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were stained blue with Hoechst dye (for live-cell imaging) (H3750; In-
vitrogen) or DAPI (4=,6-diamidino-2-phenylindole) (for fixed cells)
(H1200; Vector Laboratories). Epifluorescence and confocal images were
acquired and analyzed using Zeiss Axiovision and Zen 2010 software,
respectively.
Flow cytometric assessment. NRCMs were incubated with Lyso-
Tracker Red (1 mmol/liter for 15 min) to assess lysosome abundance, with
nonyl-acridine orange (NAO) (a cardiolipin-binding dye; 10 nmol/liter
for 15 min) and Mitotracker Green (200 nmol/liter for 45 min) to assess
mitochondrial mass, with JC-1 (10 mg/ml for 10 min) or tetramethylrho-
damine, ethyl ester (TMRE; 50 nmol/liter for 30 min) to assess mitochon-
drial polarization, and with carboxy-H2DCFDA (a cell-permeating ROS
indicator; 10mol/liter for 30 min) to assess the levels of ROS. Following
incubation with these compounds at 37°C in 5% CO2, the cells were
trypsinized and subjected to flow cytometry on a FACScan instrument
(Becton-Dickinson) as previously described (15). Cyflogic software (Cy-
Flo) was employed to analyze 20,000 events per run.
Assessment of mitochondrial DNA content. Mitochondrial DNA
content was assessed by quantitative PCR analysis as previously described
(29). Briefly, DNA was prepared from NRCM pellets, and real-time quan-
titative PCR was performed for the mitochondrial gene NADH2 (with
primers 5=-ATCACCACCATTCTCGCAAT-3= and 5=-TCCTATGTGGG
CAATTGATG-3=) and the nuclear gene RCAN1 (with primers 5=-GGTT
TGCTGAGCCTCGAAG-3= and 5=-CTTCATCCCTCCTTTGTAAC-3=).
The ratio of copies of mitochondrial to nuclear genes represents the rela-
tive mitochondrial DNA content.
Assessment of mitochondrial fragmentation. Mitochondrial mor-
phology was ascertained to be fragmented or tubular by visual inspection
of individual cells at a high magnification, as described previously (30).
Fifty cells were evaluated per experimental group, and results are ex-
pressed as percentages of cells showing predominantly fragmented mito-
chondria.
Assessment of mitochondrial polarization. Mitochondrial depolar-
ization was assessed by expression of TMRE or with the ratiometric dye
JC-1, which aggregates into red fluorescent polymers in normally polar-
ized mitochondria but is predominantly observed as green fluorescent
monomers in cells with depolarized mitochondria, as previously de-
scribed (6, 15).
TEM. NRCMs were fixed in modified Karnovsky’s fixative (3% glu-
taraldehyde, 1% paraformaldehyde in 0.1 M sodium cacodylate buffer),
followed by postfixation in 2% osmium tetroxide in 0.1 M sodium caco-
dylate buffer for 1 h. The cells were then stained with 2% aqueous uranyl
acetate for 30 min, dehydrated in a series of graded ethanol concentra-
tions, and embedded in PolyBed (Polysciences). Blocks were sectioned at
a 90-nm thickness, poststained with Venable’s lead citrate, and viewed
with a JEOL model 1200EX transmission electron microscope (TEM)
(JEOL, Tokyo, Japan). Digital images were acquired using an AMT Ad-
vantage HR (Advanced Microscopy Techniques, Danvers, MA) high-def-
inition charge-coupled device (CCD) 1.3-megapixel TEM camera.
Assessment of promoter-driven luciferase activity.A total of 3 104
cells were plated per well of a 96-well plate and transfected with the
PGL3.Luc vector, carrying a 2,760-bp fragment of the human PPARGC1
promoter (for firefly luciferase expression), and the pRL-SV40 vector (for
Renilla luciferase expression [31]) at a 100:1 ratio, using Lipofectamine
2000 (Invitrogen). Constructs coding for the human PPARGC1 pro-
moter (GenBank accession number NG_028250.1) with individual mu-
tations in the three CLEAR sites detected within (as depicted in Fig. 9D)
were generated by site-directed mutagenesis using a QuikChange Light-
ning site-directed mutagenesis kit (Stratagene) and verified by sequenc-
ing. Luciferase activity was measured with a dual-luciferase assay kit (Pro-
mega) and a Tecan Infinite M200 Pro microplate reader (Tecan)
following the manufacturers’ instructions. Firefly luciferase values were
normalized to those for Renilla luciferase to control for transfection effi-
ciency. To assess whether the bp 18 site mutant construct retained ac-
tivity to drive transcriptional activation (other than that driven by TFEB),
HEK293 cells were transfected with the PGL3.Luc vector, driven by the
human PPARGC1 promoter without (i.e., wild-type promoter) or with
mutations in the “CLEAR sequence,” located 69 bp upstream of the tran-
scriptional start site (i.e., 18 CLEAR site mutant), together with pRL-
SV40 for Renilla luciferase expression (at a ratio of 100:1). In addition,
cells were cotransfected with expression vectors coding for the constitu-
tively active transcription factor CREB, the CREB activator TORC2 (i.e.,
CRTC2) (see below for details), TFEB (pAd-CMV/V5-hTFEB), or LacZ
(pAd-CMV/V5-LacZ) (as a control), and luciferase activities were mea-
sured 48 h after transfection. Firefly luciferase readings were normalized
to those for Renilla luciferase to control for transfection efficiency.
Subcellular fractionation. NRCMs were subjected to biochemical
fractionation to recover nucleus-enriched and cytoplasmic fractions,
as previously described (23). Hearts were fractionated into nucleus-
enriched and cytoplasmic samples by using a CelLytic NuCLEAR ex-
traction kit (Nxtract; Sigma). Expression of proteins localized to the
nucleus (histone H3) and cytoplasm (glyceraldehyde-3-phosphate de-
hydrogenase [GAPDH]) was examined to confirm relative enrich-
ment.
Coimmunoprecipitation studies. Murine embryonic fibroblasts
(MEFs) from C57BL/6 wild-type mice were adenovirally transduced with
beclin-1–HA (MOI  100) or transfected with N-terminal HA-tagged
TSC1 (Addgene) (32). Three hundred micrograms of protein was incu-
bated with anti-HA (H3663; Sigma) or normal rabbit IgG, and immuno-
precipitation was performed using DynaBeads (Invitrogen).
Immunoblotting. Immunoblotting was performed on cellular ex-
tracts by use of previously described techniques (15). Antibodies em-
ployed were as follows: antibodies for FLAG (F3165; Sigma), HA (H6908;
Sigma), LAMP1 (AB24170; Abcam), beclin-1 (ab16998 [Abcam] and sc-
11427 [Santa Cruz]), p70S6K (2708; Cell Signaling), p-p70S6K (9234; Cell
Signaling), 4-EBP1 (9644; Cell Signaling), p-4EBP1 (2855; Cell Signaling),
p-mTOR (2974; Cell Signaling), mTOR (2983; Cell Signaling), histone H3
(9715; Cell Signaling), TFEB (MBS120432; employed to detect adenovi-
rally transduced HA-tagged human TFEB when HA detection was pre-
cluded for specificity), GAPDH (ab22555; Abcam), peroxisome prolifera-
tor-activated receptor gamma coactivator 1 (PGC1) (ab106814;
Abcam), tuberous sclerosis complex 1 (TSC1) (6935; Cell Signaling), and
tuberous sclerosis complex 2 (TSC2) (3612; Cell Signaling). Murine TFEB
was detected with a Bethyl Labs antibody (A303-673A). The multiple
immunoreactive TFEB bands observed (see Fig. 12C and D) likely repre-
sent various TFEB isoforms (NP_001155194.1 and NP_035679.3) or
posttranslationally modified forms of the protein in the myocardium.
Immunoblotting for -sarcomeric actin (SA) (ab52219; Abcam) was
employed as a loading control unless otherwise indicated. ImageJ software
was employed for quantitative analysis. Protein abundance was normal-
ized to -sarcomeric actin protein expression and reported as the fold
change versus the control. Chemicals employed were as follows: 3-methyl-
adenine (3MA; EMD4Biosciences), torin-1 (Tocris), MG-132 (Cayman
Chemical Company), and MnTMPyP (Calbiochem). Equivalent quanti-
ties of appropriate diluent were employed as controls in all studies in
which these chemicals were employed.
Quantitative PCRanalysis formRNA.Real-time PCR was performed
as described previously (6). Briefly, total RNA was prepared from NRCMs
by use of an RNA-easy minikit (Qiagen), and cDNA was synthesized with
1g of total RNA by using the SuperScript III first-strand synthesis system
(Invitrogen). One microliter of cDNA template was mixed with 12.5l of
2 SYBR green PCR master mix (Invitrogen) and subjected to quantita-
tive PCR in triplicate under the following conditions: 50°C for 2 min and
95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min
in an ABI7500 Fast real-time PCR system. The GAPDH gene was also
amplified in parallel as a reference for the quantification of transcripts.
Primer sets employed are shown in Table 1. Results were calculated using
the 		CT method and expressed as previously described (6).
ChIP assays. Chromatin immunoprecipitation (ChIP) was per-
formed as previously reported (25, 33). Briefly, HEK293A cells were trans-
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fected with the empty pAAV-CMV-TFEB-IRES-GFP construct, described
earlier (34), or with empty vector (as a control) for 48 h. Cells were col-
lected, fixed with 1% formaldehyde for 10 min, and lysed on ice with ChIP
lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% Triton X-100,
1% Tween 20) for 20 min. The lysate was digested with micrococcal nu-
clease (Sigma) for 15 min at 37°C, and the reaction was terminated using
EDTA (2 mM) and sodium dodecyl sulfate (SDS; 1%). SDS-Out (Pierce)
was employed to precipitate the unbound SDS, and lysates diluted 1:1
with ChIP dilution buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.5%
Triton X-100, 2 mM EDTA) were incubated with high-capacity Neutr-
Avidin agarose (Pierce). Biotinylated anti-FLAG antibody (F9291; Sigma)
or isotype control IgG1 (M9035; Sigma) was precoupled with Neutr-
Avidin beads for 30 min at 4°C, and the protein-DNA complexes were
immunoprecipitated overnight at 4°C. After six washes, the DNA was
eluted by addition of 8 mM biotin, 1% SDS in Tris-EDTA (TE) buffer and
precipitated after reversing the cross-linkage by use of 200 mM NaCl at
65°C overnight. PCR was performed using primers flanking the CLEAR
site 18 bp upstream of the transcriptional start site (forward primer, 5=-C
GTCACGAGTTAGAGCAGCA-3=; and reverse primer, 5=-TCGCCCTTA
AGCTTTTTCAA-3=) (204-bp amplicon). An additional primer set within
an adjacent segment located between the CLEAR sites at bp 18 and
469 (forward primer, 5=-CTGTCATGAAACAGGGAGCTTT-3=; and
reverse primer, 5=-GCTTTGAATGCCACAGACTCTA-3=) (125-bp am-
plicon) did not generate a product, demonstrating specificity (data not
shown).
Statistical analysis. Results are expressed as means
 standard errors
of the means (SEM), with the sample size (n) per group indicated in the
figure legends. Assumptions of normality and equality of variance were
verified, following which statistical differences were assessed with un-
paired 2-tailed Student’s t test for two experimental groups, one-way anal-
ysis of variance (ANOVA) for multiple groups, and two-way ANOVA for
testing of two variables across multiple groups, using SPSS software. Bon-
ferroni’s and Dunnett’s T3 post hoc tests were employed after ANOVA for
testing for significant differences between groups for data with equal and
unequal variances, respectively. Nonparametric tests were employed for
data that were not normally distributed. A two-tailedP value of0.05 was
considered statistically significant.
RESULTS
BNIP3 expression increases beclin-1 abundancewith transcrip-
tional suppression of autophagy-lysosomemachinery.BNIP3, a
Bcl-2 family prodeath protein, is transcriptionally induced in car-
diac IR injury and provokes mitochondrial permeabilization (8,
11, 12). We have observed that BNIP3 expression provokes pro-
gressive declines in lysosome numbers, with accumulation of frag-
mented and depolarized mitochondria, leading to cell death (15),
and that restoring lysosome biogenesis by exogenous TFEB ex-
pression reestablishes mitochondrial autophagy to rescue BNIP3-
induced cell death (15). To examine the mechanisms for impaired
autophagic removal of BNIP3-damaged mitochondria, we evalu-
ated the regulation of the autophagy-lysosome machinery by ad-
enoviral transduction of NRCMs with BNIP3. We hypothesized
that the decline in lysosome number is driven by BNIP3-induced
autophagy, as also observed early during starvation-induced au-
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tophagy (18). However, BNIP3-induced declines in lysosome
abundance (assessed with the acidophilic dye LysoTracker Red
[Fig. 1A to C] and by immunostaining for LAMP1 [a candidate
lysosomal protein whose levels are used to track lysosome abun-
dance {35}] [Fig. 1A]) and in LAMP1 protein abundance (Fig. 1D
and E) were only partially restored with 3MA (a type III phospha-
tidylinositol 3-kinase inhibitor which inhibits autophagosome
formation) (Fig. 1A to E), to 65%, 59%, and 72%, respectively, of
the levels for similarly treated controls. This indicates that lyso-
some consumption in BNIP3-induced autophagy is only partly
responsible for the observed decline in lysosome abundance (15).
Importantly, we observed progressive declines in LAMP1 tran-
scripts (Fig. 1H) paralleling the decline in LAMP1 protein abun-
dance (Fig. 1F and G). This transcriptional suppression also af-
fected multiple proteins (Fig. 1I) that participate in autophagy
(LC3, p62, and RAB7), constitute the lysosomes (LAMP2A,
LAMP2B, cathepsin B, and cathepsin D), and function as the mas-
ter transcriptional regulator of the autophagy-lysosome machin-
ery (TFEB) but did not alter expression of the unrelated ribosomal
proteins RPL32 and RPS12 (changes in transcript/GAPDH abun-
dances of 0.95- 
 0.02-fold [versus 1.01- 
 0.03-fold for LacZ]
and 0.95-
 0.03-fold [versus 1.04-
 0.03-fold for LacZ], respec-
tively; the P value was nonsignificant [NS]; n  8). Taken to-
gether, these observations indicate that in contrast to the well-
described transcriptional stimulation of the autophagy-lysosome
machinery observed with starvation (21–24), BNIP3 expression
results in transcriptional suppression of this machinery to prevent
its replenishment, while autophagy is robustly induced to remove
BNIP3-damaged mitochondria (15).
We and others have observed a rapid increase in beclin-1
abundance with reperfusion/reoxygenation injury (5, 6), and
elevated beclin-1 levels transcriptionally suppress autophagy-
lysosome machinery genes (6). Since BNIP3 expression is pos-
tulated to displace beclin-1 from its binding to Bcl2 as a mech-
anism for induction of autophagosome formation (14), we
examined the effect of BNIP3 expression on beclin-1. Beclin-1
protein abundance was increased early (at 12 and 24 h) after
BNIP3 transduction (Fig. 2A and B), and this was not due to
transcriptional induction (Fig. 2C). In fact, BECN1 transcript
levels were significantly reduced compared with those of con-
trols at 24 h, coinciding with the suppression of other au-
tophagy-lysosome machinery transcripts (Fig. 1I), and only
increased subsequently, in parallel with a decline in beclin-1
protein abundance (Fig. 2B and C) secondary to consumption
with persistent autophagy (data not shown). This suggests that
a stabilization of beclin-1 protein results in its accumulation
early after BNIP3 expression.
We next examined if ROS mediate the BNIP3-induced in-
crease in beclin-1 abundance observed with reperfusion injury
(6). BNIP3 triggered ROS generation early after its expression
(at 12 h) (Fig. 2D and E), likely as a result of mitochondrial
depolarization (Fig. 2F and G). Scavenging of ROS with
MnTMPyP, a cell-permeating superoxide dismutase mimetic,
did not affect BNIP3-induced mitochondrial depolarization
(Fig. 2F and G) but prevented the increase in beclin-1 abun-
dance (Fig. 2H and I), indicating that BNIP3-induced mito-
chondrial permeabilization is the cause rather than the conse-
quence of ROS generation, which provokes increased beclin-1
abundance. Treatment with MnTMPyP induced reductions in
LAMP1 transcripts (Fig. 2J) and protein levels (Fig. 2K and L),
consistent with prior reports indicating that basal ROS levels
may drive transcription of lysosomal genes (36). Importantly,
treatment with MnTMPyP prevented BNIP3-induced declines
in LAMP1 transcripts (Fig. 2J) and protein (Fig. 2K and L) and
in lysosomes (Fig. 2M and N) and attenuated BNIP3-induced
cardiomyocyte death (Fig. 2O). Taken together, these observa-
tions indicate that BNIP3-induced ROS mediate increased
FIG 1 BNIP3 expression results in transcriptional downregulation of autophagy-lysosome machinery. (A) Confocal images demonstrating LysoTracker
fluorescence (top) and LAMP1 expression (bottom) in NRCMs transduced with BNIP3 (green) or LacZ (24 h), with or without 3MA (7 mmol/liter) and with
quantitation of the number of LAMP1-positive dots/nucleus. *, #, and $, P  0.05 versus LacZ, BNIP3, and BNIP3 plus 3MA, respectively. (B and C)
Representative flow cytometric tracings (B) and quantitation (C) of LysoTracker fluorescence (n 3). *, P 0.05 versus control (con) (white bar). (D and E)
Representative immunoblot (D) and quantitation (E) for LAMP1 in NRCMs treated as described for panel A (n 3). *, P 0.05 versus control (white bar). (F
to H) Representative immunoblot (as previously described [15]) (F) and quantitation of LAMP1 protein (n 3) (G) and LAMP1 transcripts (n 4 to 6) (H) in
NRCMs transduced with BNIP3 or LacZ for the indicated durations. (I) Levels of representative autophagy-lysosome machinery transcripts in NRCMs
transduced with BNIP3 or LacZ (24 h; n 8). All transductions were performed at an MOI of 100/sample.
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beclin-1 abundance and the observed transcriptional suppres-
sion of the lysosome machinery.
Partial beclin-1 knockdown transcriptionally stimulates au-
tophagic flux to attenuate BNIP3-induced cardiomyocyte
death. We have observed that experimental modulation of
beclin-1 levels transcriptionally affects autophagy-lysosome ma-
chinery proteins in a reciprocal fashion (6). To determine if
BNIP3-induced upregulation of beclin-1 contributes to the ob-
served decline in LAMP1, we performed a partial knockdown of
BECN1 transcripts (with two different shRNA constructs) in
BNIP3 (and LacZ)-treated NRCMs. Partial beclin-1 knockdown
(reduction in BECN1 transcripts to69% of control level and in
beclin-1 protein to 45 to 50% of control level) (Fig. 3A to C)
stimulated LAMP1 transcription (Fig. 3D) and increased lyso-
some abundance (Fig. 3E and F) to prevent BNIP3-induced de-
clines in lysosome numbers (Fig. 3E and F). BNIP3 expression
resulted in autophagosome accumulation, indicating impaired
autophagic flux (15), and partial beclin-1 knockdown increased
the relative abundance of autolysosomes and reduced the level of
autophagosomes (versus the shLacZ control) in BNIP3-trans-
duced NRCMs (Fig. 3G and H), pointing to enhanced autophagic
flux. Partial beclin-1 knockdown also resulted in an increased
abundance of autophagy proteins (total LC3 and p62) (Fig. 3I),
which was transcriptional as we described earlier (6; data not
shown), and in LAMP1 (Fig. 3I and J), paralleling the increased
lysosome abundance. Importantly, partial beclin-1 knockdown
attenuated the BNIP3-induced decline in LAMP1 protein (Fig. 3I
and J), reduced BNIP3-induced TUNEL positivity (Fig. 3K and L),
and prevented BNIP3-induced cell death (Fig. 3M), mimicking
the observations seen with exogenous expression of TFEB (15).
Interestingly, partial beclin-1 knockdown resulted in reduced
BNIP3 protein, which was prevented by concomitant inhibition
of autophagosome formation with 3MA (Fig. 3N) but not by pro-
teasome inhibition with MG-132, suggesting an enhanced au-
tophagic degradation of BNIP3 together with the mitochondria,
whereupon it is localized. Partial beclin-1 knockdown with the
FIG 2 BNIP3-induced ROS drive increased beclin-1 protein levels and suppression of lysosome abundance. (A to C) Representative immunoblot (A) and
quantitation of beclin-1 protein (n 3) (B) and BECN1 transcripts (n 3 or 4) (C) in NRCMs transduced with BNIP3 or LacZ for the indicated durations. (D
and E) Representative flow cytometric tracings (D) and quantitation (E) of ROS (n 3 or 4) in NRCMs transduced with BNIP3 or LacZ for 12 h. H2O2 (500
mmol/liter; 4 h) was used as the positive control. (F and G) Representative flow cytometric tracings (F) and quantitation (G) of TMRE fluorescence (n 3) in
NRCMs treated as described for panel D. (H and I) Representative immunoblot (H) and quantitation (I) of beclin-1 (n 3 or 4) in NRCMs transduced with
BNIP3 or LacZ plus MnTMPyP (50 mol/liter; 24 h). (J to L) LAMP1 transcript (n 6) (J) and protein (representative immunoblot [K] and quantitation [L]
[n 4]) abundances in NRCMs treated as described for panel H. (M and N) Representative flow cytometric tracings (M) and quantitation (N) of LysoTracker
fluorescence (n 3). (O) Cell death in NRCMs treated as described for panel H (n 7 or 8). All transductions were performed at an MOI of 100/sample. *, P
0.05 versus control (white bars).
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second shRNA construct (shBECN1-2) (Fig. 3A to D) recapitu-
lated these findings (data not shown). Taken together, these data
indicate that partial beclin-1 knockdown transcriptionally stimu-
lates autophagic flux to restore impaired autophagosome process-
ing with BNIP3 expression.
Notably, as we observed previously (6), a more complete
knockdown of BECN1 (with 10-fold higher adenoviral shBECN1
transduction, to13% of transcript levels with shLacZ, resulting
in a reduction of beclin-1 protein abundance to7% of the con-
trol level) (Fig. 4A and B) resulted in inhibition of autophagosome
formation (Fig. 4C and D) and increased BNIP3-induced cell
death (Fig. 4E), consistent with an obligate role for beclin-1 in
initiation of autophagy (26).
Partial beclin-1 knockdown activates TFEB to attenuate
BNIP3-induced cardiomyocyte death. Intriguingly, the effects of
partial beclin-1 knockdown (Fig. 3) mimicked our observa-
tions with TFEB activation (15). Therefore, we evaluated the
effect of partial beclin-1 knockdown on TFEB activation. Re-
cent studies uncovered a tightly regulated mechanism for TFEB
activation, whereby TFEB is phosphorylated and sequestered
in the cytoplasm, in the unstressed state, and starvation-in-
duced mTOR inactivation provokes dephosphorylation and
nuclear translocation of TFEB (21, 22, 24). Given the lack of
suitable antibodies to detect endogenous TFEB in rat cells (24),
we examined the effect of starvation on subcellular distribution
of exogenous TFEB in NRCMs. Exogenous TFEB expressed at
FIG 3 Partial beclin-1 knockdown stimulates lysosome biogenesis and induces autophagic flux to attenuate BNIP3-induced cell death. (A) BECN1 transcript
levels in NRCMs transduced with two shBECN1 constructs or shLacZ (MOI  1; 72 h). (B and C) Representative immunoblot (B) and quantitation (C) of
beclin-1 protein (n  4) in NRCMs treated as described for panel A. *, P  0.05 versus shLacZ. (D) LAMP1 transcript levels in NRCMs treated as described
for panel A and cotransduced with BNIP3 or LacZ (MOI  100; 24 h) (n  4 to 12). * and #, P  0.05 versus control (white bar) and the respective
shBECN1-treated group, respectively. (E and F) Representative flow cytometric tracings (E) and quantitation (F) of LysoTracker fluorescence in NRCMs
transduced with shBECN1-1 or shLacZ and cotransduced with BNIP3 or LacZ as described for panel D (n  3). (G and H) mCherry-GFP-LC3 localization
(magnification,630; representative of 3 experiments) (G) and quantitation of autophagosomes, autolysosomes, and both (H) in NRCMs treated as described
for panel B (n 20 to 40 nuclei/group). *, #, and $,P 0.05 for autophagosomes, autolysosomes, and both, respectively, versus shLacZ-plus-LacZ control. (I and
J) Immunoblot depicting autophagy-lysosome proteins (I) and quantitation of LAMP1 (n 3) (J) in NRCMs treated as described for panel E. *, P 0.05 versus
control (white bar). (K and L) Representative images (magnification,200) (K) and quantitation of TUNEL positivity (green in panel K) (n 4) (L). (M) Cell
death in NRCMs treated as described for panel E (n  20 to 24). *, P  0.05 versus control (white bar). (N) BNIP3 expression in NRCMs transduced with
shBECN1-1 or shLacZ (MOI  1; 72 h) and cotransduced with BNIP3 or LacZ (MOI  100; 24 h), with or without 3MA (7 mmol/liter) or MG-132 (10
mol/liter).
FIG 4 Nearly complete beclin-1 knockdown inhibits autophagy to increase BNIP3-induced cell death. (A) BECN1 transcript levels in NRCMs transduced with
shBECN1-1, shBECN1-2, or shLacZ (MOI  10; 72 h). (B) Representative immunoblot (top) and quantitation (bottom) of beclin-1 protein abundance in
NRCMs treated as described for panel A (n 4). *, P 0.05 versus shLacZ. (C and D) GFP-tagged LC3 localization (magnification,630; representative of 3
experiments) (C) and quantitation of punctate GFP (D) in NRCMs treated as described for panel A and cotransduced with BNIP3 or LacZ (24 h) (n 15 to 20
cells/group). * and #,P 0.05 versus control (white bars) and the BNIP3-plus-shLacZ group, respectively. (E) Cell death in NRCMs treated as described for panel
C (n 7 to 15). *, P 0.05 versus control (white bar).
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low levels localized to the cytoplasm in resting cardiomyocytes
and rapidly translocated to the nucleus with starvation and
torin-1 treatment (Fig. 5A), via inhibition of mTOR activity (as
evidenced by a reduction in Thr-389 phosphorylation of S6
kinase [S6K], Thr-37/46 phosphorylation of 4E-binding pro-
tein 1 [4EBP-1], and Ser-2481 autophosphorylation of mTOR)
(Fig. 5B to D). Torin-1-induced mTOR inhibition provoked an
increase in faster-migrating (i.e., dephosphorylated) forms of
TFEB (Fig. 5B) and markedly increased TFEB abundance in the
nucleus-enriched fraction in cardiac myocytes (Fig. 5E), as ob-
served in other cell types (21, 22, 24).
Partial beclin-1 knockdown also resulted in activation of TFEB
with increased nuclear localization (Fig. 5A) and in increases in
faster-migrating forms (Fig. 5C, D, F, and G) and nuclear TFEB
levels compared to those of the control (Fig. 5F and G). To deter-
mine the mechanism for TFEB activation, we examined mTOR
activity with partial beclin-1 knockdown, which revealed reduc-
tions in 4EBP-1 phosphorylation and mTOR autophosphoryla-
FIG 5 Partial beclin-1 knockdown activates TFEB to attenuate BNIP3-induced cell death. (A) Subcellular distribution of TFEB (magnification, 630) in
NRCMs transduced with HA-TFEB (MOI 1; 24 h), with or without torin-1 (250 nmol/liter; 1 h), subjected to starvation (4 h), or transduced with shBECN1-1,
shBECN1-2, or shLacZ (MOI 1; 72 h), with quantitation of cells with nuclear TFEB (numbers below the panels). * and #, P 0.05 versus diluent and shLacZ,
respectively. (B to D) Immunoblots depicting TFEB and phosphorylation of S6K, 4EBP-1, and mTOR in NRCMs treated as described for panel A. (E to G)
Immunoblots depicting TFEB in NRCMs treated with torin-1, shBECN1-1, and shBECN1-2 as described for panel A, followed by biochemical fractionation into
cytoplasmic (GAPDH-expressing) and nucleus-enriched (histone H3-expressing) fractions. White lines separate parts of the same gel. The data for panels A to
G are representative of 2 experiments. (H and I) TFEB (H) and LAMP1 (I) transcript levels in NRCMs transduced with shBECN1 constructs (or shLacZ), with
or without shTFEB (MOI 1; 72 h) (n 4). (J) Cell death in NRCMs transduced with shBECN1-1 (or shLacZ), with or without shTFEB (MOI 1; 72 h), and
cotransduced with BNIP3 or LacZ (MOI 100; 24 h) (n 7 or 8). *, P 0.05 versus control (white bars).
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tion, without a change (or even an increase) in S6K phosphoryla-
tion (Fig. 5C and D), suggesting that mTOR inactivation may be
partial and/or S6K phosphorylation may be affected simultane-
ously by mTOR-independent mechanisms (37). Indeed, complete
inhibition of mTOR with torin-1 resulted in further TFEB activa-
tion in shBECN1-treated cells, as evidenced by the appearance of
faster-migrating (dephosphorylated) TFEB bands (Fig. 5C and
D). Interestingly, TFEB protein abundance was modestly reduced
with partial beclin-1 knockdown and starvation-induced activa-
tion (but not with torin-1) (Fig. 5B to G), suggesting an enhanced
degradation of activated TFEB, as observed previously (22, 38).
Partial beclin-1 knockdown also resulted in a marked increase in
endogenous TFEB transcripts (Fig. 5H), consistent with the ob-
servation that activated TFEB induces its own transcription (25).
Importantly, simultaneous knockdown of endogenousTFEB (Fig.
5H) prevented the transcriptional upregulation of LAMP1 (Fig.
5I) and negated the salutary effects of partial beclin-1 knockdown
on BNIP3-induced cardiomyocyte death (Fig. 5J), indicating that
the effects of partial beclin-1 knockdown are transduced via acti-
vation of endogenous TFEB.
Conversely, consistent with the observation that exogenous
beclin-1 is sufficient to suppress transcription of autophagy-lyso-
some proteins and inhibit autophagic flux (6), exogenous beclin-1
provoked a decline in lysosome abundance (Fig. 6A and B), with a
marked reduction in nuclear TFEB (Fig. 6C) as well as in the
abundance of total TFEB (Fig. 6D and E), driven by enhanced
proteasomal degradation. This was likely the result of the
beclin-1-induced increase in mTOR activation (Fig. 6F). beclin-1
interacts with TSC1 (Fig. 6G), as previously described (39), with
increased TSC1 and reduced TSC2 abundance (Fig. 6H to J), sug-
gesting a mechanism whereby recruitment of TSC1 away from
TSC2 increases its degradation, driving increased mTOR activa-
tion via sustained Rheb activity (40, 41). Taken together, these
findings indicate that beclin-1 levels reciprocally regulate TFEB
activity.
Partial beclin-1 knockdown restores normally polarizedmi-
tochondria in BNIP3-expressing cells. BNIP3 expression re-
sulted in mitochondrial fragmentation, and partial beclin-1
knockdown restored the filamentous appearance of the mito-
chondrial network in BNIP3-expressing cells (Fig. 7A). Ultra-
structural examination of BNIP3-transduced cardiomyocytes re-
vealed widespread mitochondrial swelling and fragmentation and
effacement of cristae, with a marked increase in prevalence of
autophagic structures, and concomitant partial beclin-1 knock-
down restored structurally normal-looking mitochondria in
BNIP3-expressing cells (Fig. 7B). Concomitant partial beclin-1
knockdown also significantly reduced the prevalence of BNIP3-
depolarized mitochondria (Fig. 7C and D), consistent with their
increased autophagic removal, as observed with exogenous ex-
pression of TFEB (15).
BNIP3 expression resulted in reduced mitochondrial mass, as
evidenced by reduced NAO fluorescence (Fig. 7E and F) and a
reduced mitochondrial DNA content (Fig. 7G). Interestingly, par-
tial beclin-1 knockdown significantly increased NAO fluorescence
(Fig. 7E and F), with a trend toward increased mitochondrial
DNA (Fig. 7G), in LacZ-treated controls; restored the mitochon-
drial mass in BNIP3-expressing cells (Fig. 7E to G); and prevented
the decline in cellular ATP content with BNIP3 expression (Fig.
7H). Taken together, these data indicate that partial beclin-1
knockdown restores normal mitochondria in BNIP3-expressing
NRCMs.
Partial BECLIN1 knockdown concomitantly stimulates mi-
tochondrial biogenesis via TFEB to rescue BNIP3-induced cell
death. The effects of partial beclin-1 knockdown (Fig. 7A to F)
mimicked those of exogenous TFEB in BNIP3-expressing cells
(15) and suggested a concomitant induction of mitochondrial
biogenesis (Fig. 7E to G), as observed with TFEB activation in
noncardiomyocytes (25, 42). Indeed, exogenous TFEB localized
to the nuclei of NRCMs at increasing doses irrespective of another
stimulus, such as starvation (Fig. 8A), resulting in increased au-
tophagic structures and lysosomes, indicating stimulation of
autophagy and lysosome biogenesis (Fig. 8B), and in increased
mitochondrial mass (Fig. 8C to F), indicating that TFEB is suffi-
cient to stimulate mitochondrial biogenesis in NRCMs.
We observed that TFEB regulated the abundance of tran-
scripts for PGC1 (a modulator of mitochondrial biogenesis
[1, 43]) in both resting and starved NRCMs (Fig. 9A to C)
and that exogenous TFEB activated transcription from a
PPARGC1 promoter-luciferase reporter construct (Fig. 9D).
We proceeded to individually mutate the three TFEB-binding
E-boxes (termed “CLEAR” sites, with only one base pair mis-
match at a degenerate location compared with the ideal site
annotated for maximal activation [33]) in the human
PPARGC1 promoter (Fig. 9D, left panel). Only mutations
within the CLEAR sequence located 18 bp upstream from the
transcriptional start site completely ablated the responsiveness
to TFEB (Fig. 9D, right panel), and we confirmed TFEB binding
at this site by use of a ChIP assay (with a primer pair flanking
this site) (Fig. 9E). Importantly, the bp 18 mutant construct
retained intact activity toward CREB (44) and TORC2 (45),
two known inducers of PPARGC1 transcription (Fig. 9F),
confirming a specific effect of TFEB on PGC1 transcription
via binding to this site.
Multiple observations suggested an impairment of TFEB acti-
vation in the setting of BNIP3-induced autophagy, namely, reduc-
tions in autophagy-lysosome gene and TFEB transcripts (Fig. 1I)
and the accompanying impairment of autophagic flux (Fig. 3G
and H) and a rescue of BNIP3-induced cell death with exogenous
TFEB (15) and with partial beclin-1 knockdown-mediated TFEB
activation (Fig. 5). Indeed, we observed a reduction in the nuclear
TFEB level in BNIP3-expressing cells (by 33%; P 0.005; n 3)
(Fig. 10A), accompanied by mTOR activation (fold change in p-
mTOR/mTOR abundances, 1.6
 0.1 in BNIP3 versus 1.0
 0.1 in
control; P 0.005; n 4), as the possible mechanism (Fig. 10B).
We also found a marked reduction of PGC1 protein abun-
dance in BNIP3-expressing NRCMs (Fig. 10C and D), which was
driven by reduced PGC1 transcription (Fig. 10E and F) and res-
cued by concomitant TFEB expression (Fig. 10C and D). To ex-
amine if the beclin-1 protein affects mitochondrial biogenesis via
the TFEB-PGC1 axis, we evaluated the effect of modulating be-
clin-1 levels on PGC1 transcription by using loss of function and
gain of function of beclin-1. Partial beclin-1 knockdown induced
PPARGC1 transcription in a TFEB-dependent manner (Fig.
10G), and conversely, beclin-1 overexpression suppressed
PPARGC1 promoter activity, which could be rescued with exog-
enous TFEB (Fig. 10H). Taken together, these findings suggest
that BNIP3-induced beclin-1 upregulation may also impair mito-
chondrial biogenesis via attenuation of TFEB activity and a de-
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cline in PGC1 expression, contributing to reduced mitochon-
drial mass (Fig. 7E to G).
In further studies, suppression of endogenous PGC1 (by
PGC1 knockdown) (Fig. 9G) prevented the increase in mito-
chondrial mass with partial beclin-1 knockdown (and exogenous
TFEB) (Fig. 10I and J), increased cell death in BNIP3-expressing
NRCMs (as well as in controls) (Fig. 10K), and resulted in atten-
uated cytoprotection with partial beclin-1 knockdown in BNIP3-
FIG 6 Exogenous beclin-1 inactivates TFEB. (A and B) Representative flow cytometric tracings (A) and quantitation (B) of LysoTracker fluorescence in NRCMs
transduced with beclin-1 or LacZ (MOI 100; 48 h) (n 6). (C) Immunoblot (IB) demonstrating subcellular distribution of TFEB in NRCMs transduced with
HA-TFEB (MOI  1), treated as described for panel A, and subjected to subcellular fractionation into cytoplasmic and nuclear fractions. The data are
representative of 2 experiments. (D and E) Immunoblot (D) and quantitation (E) of TFEB abundance in NRCMs transduced with HA-TFEB (MOI 1) and
treated as described for panel A, with or without MG-132 (10 mol/liter; 24 h) (n 4). (F) Immunoblots for phosphorylation of S6K, 4EBP-1, and mTOR in
NRCMs transduced with beclin-1 or LacZ (MOI 100; 48 h), with or without torin-1 (250 nmol/liter; 1 h). (G) Representative immunoblot (n 2) depicting
coimmunoprecipitation (IP) of endogenous TSC1 (left) and beclin-1 (right) in MEFs expressing beclin-1–HA and HA-TSC1, respectively. (H to J) Immunoblot
(H) and quantitation of TSC1 (I) and TSC2 (J) in NRCMs treated as described for panel A (n 4).
FIG 7 Partial beclin-1 knockdown restores normal mitochondria in BNIP3-expressing cells. (A) Confocal images demonstrating COX IV expression (green) in
NRCMs transduced with shBECN1-1 or shLacZ (MOI  1; 72 h) and cotransduced with BNIP3 (red) or LacZ (MOI  100; 24 h), with the fraction of cells
demonstrating fragmented mitochondria indicated. * and #, P 0.05 versus LacZ and BNIP3, respectively. (B) TEM images of NRCMs treated as described for
panel A. Arrows point to BNIP3-damaged mitochondria. The data are representative of 2 experiments. (C and D) Representative flow cytometric tracings
demonstrating JC-1 fluorescence (C) and quantitation of cells predominantly expressing JC-1 monomers (lower right quadrants in panel C) (D) for NRCMs
treated as described for panel A (n  4). (E and F) Representative flow cytometric tracings (E) and quantitation (F) of NAO fluorescence in cells treated as
described for panel A (n 4). (G) Ratio of mitochondrial to nuclear DNA (n 3). (H) Quantitation of ATP levels in cells treated as described for panel A (n
4). *, P 0.05 versus control (white bars).
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expressing NRCMs (Fig. 10K). Conversely, exogenous PGC1
(Fig. 9H) was sufficient to attenuate BNIP3-induced cell death, in
a dose-dependent fashion (Fig. 10L). These data indicate that en-
hanced mitochondrial biogenesis via the TFEB-PGC1 axis con-
tributes to the cytoprotective effects of partial beclin-1 knock-
down in BNIP3-expressing cells.
Partial beclin-1 knockdown restores normally polarizedmi-
tochondria and attenuates hypoxia-reoxygenation-induced cell
death via TFEB. Mitochondrial permeabilization causes cell
death with cardiac IR injury (2). Given the observations that
BECN1-haploinsufficient mice demonstrate reductions in infarct
size with experimental in vivo IR injury (5) and that partial
beclin-1 knockdown facilitates autophagosome processing to at-
tenuate cell death with in vitro hypoxia-reoxygenation injury (6),
we hypothesized that hypoxia-reoxygenation injury results in in-
hibition of TFEB activity and that partial beclin-1 knockdown
activates TFEB to restore normal mitochondria and prevent hyp-
oxia-reoxygenation-induced cell death. Indeed, hypoxia-reoxy-
genation injury resulted in reduced nuclear TFEB abundance (by
56%; P  0.005; n  3) (Fig. 11A) accompanied by mTOR acti-
vation (fold change in p-mTOR/mTOR abundances of 2.1
 0.1,
versus 1.0 
 0.1 for normoxia; P  0.001; n  4) (Fig. 11B), as
previously described to occur rapidly with reperfusion in vivo
(46). This was accompanied by significant declines in LC3, p62,
RAB7, LAMP1, TFEB, and PGC1 transcript levels (but not in the
RPS12 or RPL32 transcript level) (data not shown) with hypoxia-
reoxygenation compared to the levels in normoxic controls (Fig.
11C).
To examine if suppression of TFEB activity is also observed
with in vivo IR injury, we subjected adult mice to reversible
LAD coronary artery ligation and examined autophagy-lyso-
some transcripts in the injured region and the remote myocar-
dium 4 h after reperfusion. Indeed, we observed transcriptional
suppression of TFEB (which suggests suppressed TFEB activa-
tion, as it autoregulates its transcription [25]) and various au-
tophagy-lysosome gene transcripts but not others (suggesting
that they may be regulated via parallel pathways) only in the
injured area (Fig. 11D), not in the remote myocardium (Fig.
11E). Also, as observed previously (5, 6), we confirmed that
beclin-1 abundance was increased only in the injured myocar-
dium (Fig. 11F to I), without an increase in its transcript level
(Fig. 11D and E), indicating protein stabilization. Importantly,
beclin-1 abundance was not increased in the IR-injured beclin-
1-haploinsufficient (BECN1/) myocardium compared with
a sham-treated one (Fig. 12A and B). This was associated with
increased nuclear TFEB levels in IR-injured BECN1/ com-
FIG 8 Exogenous TFEB induces mitochondrial biogenesis. (A) Subcellular distribution of TFEB (green; magnification, 400) in NRCMs transduced with
increasing doses of TFEB or LacZ, with or without starvation (4 h). The data are representative of 2 experiments. (B) TEM images of NRCMs transduced with
TFEB or LacZ (MOI 100; 48 h), demonstrating increased abundances of lysosomes (black arrows; top right) and autophagic structures (white arrows; top right)
and showing mitochondrial morphology (bottom right). The data are representative of 2 experiments. (C to F) Representative flow cytometric tracings (C) and
quantitation (D) of Mitotracker Green, mitochondrial DNA content (E), and abundances of representative mitochondrial proteins (F) in NRCMs treated as
described for panel B (n 3 or 4).
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pared with IR-injured WT myocardium (wherein nuclear
TFEB was reduced compared to the level in sham-treated WT
myocardium) (Fig. 12C and D), increased lysosomal protein
abundance (Fig. 12E to G), and stimulation of autophagic flux
in IR-injured BECN1/ myocardium (Fig. 12H to J), in con-
trast to impaired autophagic flux in IR-injured WT myocar-
dium, as we observed previously (6). BECN1 haploinsuffi-
ciency also prevented the decline in PGC1 abundance with IR
injury in WT hearts (Fig. 12K to M).
Consistent with the aforementioned effects on activation of
the TFEB-PGC1 axis, we observed that partial beclin-1
knockdown increased lysosome abundance (Fig. 13A and B)
and attenuated the increase in depolarized mitochondria
(Fig. 13C and D) and cell death (Fig. 13E) in an endogenous
TFEB-dependent manner. Notably, the effects of partial
beclin-1 knockdown on attenuation of hypoxia-reoxygen-
ation-induced cell death were partially dependent upon endog-
enous PGC1 signaling (Fig. 13F). While exogenous PGC1
was sufficient to partially attenuate hypoxia-reoxygenation-in-
duced cell death (by 19%) (Fig. 13G), exogenous TFEB con-
ferred a larger reduction (31%) (Fig. 13H), indicating that both
mitochondrial autophagy and biogenesis play critical roles in
the observed cytoprotection.
Interestingly, as observed in the setting of BNIP3 expression
(Fig. 4E), a nearly complete reduction in beclin-1 abundance in-
creased hypoxia-reoxygenation-induced cell death (Fig. 13E),
consistent with an obligate role for beclin-1 in autophagosome
formation (26).
FIG 9 TFEB stimulates PGC1 transcription in NRCMs. (A and B) PPARGC1 transcript levels in NRCMs transduced with TFEB or LacZ (MOI 100; 48 h; n 4)
(A) or with shTFEB or shLacZ (MOI  1; 72 h; n  4) (B). (C) Promoter-driven luciferase activities in NRCMs transduced with shTFEB or shLacZ
(MOI 1; 72 h), with or without starvation (6 h) (n 12 to 22). (D) (Left) TFEB target (CLEAR) sequences in the humanPPARGC1promoter, numbered backwards
from the transcriptional start site (arrow), and in mutants (crossed out). (Right) Promoter-driven luciferase activities in NRCMs transfected with the various constructs
shown at left, followed by transduction with TFEB or LacZ (MOI 100; 48 h) (n 7 to 23). (E) CHIP analysis for a PCR amplicon flanking the bp18 CLEAR site in
HEK cells transfected as described for panel A. Primers are depicted in panel D (left). Immunoprecipitation with an isotype control antibody was employed as a control
(see Materials and Methods). (F) Promoter-driven luciferase activities in HEK293 cells expressing CREB, TORC2, TFEB, or LacZ (as a control) (n4). * and #,P0.05
versus WT promoter plus LacZ (white bar) and versus bp18 CLEAR site mutant plus LacZ (5th bar from left), respectively. (G and H) Expression of PGC1 protein
in NRCMs transduced with shPPARGC1 (or shLacZ) (MOI 100) (G) or with FLAG-PGC1 or LacZ (MOI 100; 24 h) (H).
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DISCUSSION
Activation of TFEB is essential for sustaining lysosome function
and enhancing cell survival under starvation conditions (25, 47).
Our findings indicate that TFEB activation is impaired by an ROS-
induced increase in beclin-1 abundance resulting in cardiomyo-
cyte death in IR injury (Fig. 14). The following lines of evidence
support this argument. (i) BNIP3, a hypoxia-inducible protein,
permeabilizes mitochondria with ROS generation, which pro-
vokes increased beclin-1 abundance (Fig. 2) accompanied by a
decline in the nuclear TFEB level (Fig. 11) and transcriptional
FIG 10 Inhibition of TFEB-PGC1 axis provokes cell death in BNIP3-expressing NRCMs. (A) Immunoblot depicting TFEB expression in NRCMs transduced with
HA-TFEB (MOI 1; 24 h), with or without BNIP3 or LacZ (MOI 100; 24 h), followed by biochemical fractionation into cytoplasmic and nuclear fractions. (B)
Immunoblot depicting p-mTOR and total mTOR expression in NRCMs transduced with BNIP3 or LacZ (MOI100; 24 h). (C and D) Representative immunoblot (C)
and quantitation (D) of PGC1 protein in NRCMs transduced with BNIP3 or LacZ, with or without TFEB (each at an MOI of 100; 24 h) (n  4). (E and F)
Promoter-driven luciferase activities (E) and PPARGC1 transcript levels (F) in NRCMs transduced with BNIP3 or LacZ (MOI  100; 48 h) (n  6 to 9). (G)
Promoter-driven luciferase activities in NRCMs transduced with shBECN1-1 or shBECN1-2, with or without shLacZ or shTFEB (MOI  1; 72 h) (n  8 to 16).
(H) Promoter-driven luciferase activities in NRCMs transduced with beclin-1–HA or LacZ, with or without TFEB (MOI  100; 48 h) (n  8 to 15). (I and J)
Representative flow cytometric tracings (I) and quantitation (J) of NAO fluorescence in NRCMs transduced with shPPARGC1 or shLacZ (MOI 100; 72 h) and
cotransduced with TFEB or LacZ (MOI 100; 48 h) (I, left panel) or with shBECN1-1 (or shLacZ) (MOI 1; 72 h) (I, right panel) (n 4). (K) Cell death in NRCMs
transduced with shBECN1-1, shBECN1-2, or shLacZ (MOI1), with or without shPPARGC1 (MOI100; 72 h), and cotransduced with BNIP3 or LacZ (MOI100;
24 h) (n 7 or 8). *, #, and $, P 0.05 versus LacZ, the respective BNIP3-treated group, and the respective BNIP3-plus-shPPARGC1-treated group, respectively. (L)
Cell death in NRCMs transduced with FLAG-PGC1 or LacZ and BNIP3 or LacZ (MOI 100), all for 24 h (n 7 or 8).
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suppression of the autophagy-lysosome machinery (Fig. 1). (ii)
Hypoxia-reoxygenation injury, which triggers ROS-induced up-
regulation of beclin-1 early after reoxygenation (5, 6), also results
in inactivation of TFEB, with transcriptional suppression of the
autophagy-lysosome machinery, a finding mirrored early after in
vivo ischemia-reperfusion insult specifically in the IR-injured seg-
ment (Fig. 12 and 13). (iii) Partial beclin-1 knockdown transcrip-
tionally stimulates the autophagy-lysosome machinery via activa-
tion of TFEB (Fig. 3 and 5) to facilitate removal of damaged
mitochondria and attenuate cardiomyocyte death with BNIP3 ex-
pression (Fig. 3) and hypoxia-reoxygenation injury (Fig. 13). (iv)
BECN1 haploinsufficiency prevents the decline in nuclear TFEB
and impairment in autophagic flux observed with IR injury (Fig.
12). (v) Partial beclin-1 knockdown induces TFEB-mediated up-
regulation of PGC1 to stimulate mitochondrial biogenesis (Fig.
10), which restores the mass of normally polarized mitochondria
under these conditions (Fig. 7 and 13). Interestingly, partial be-
clin-1 knockdown-mediated cytoprotection with hypoxia-reoxy-
genation injury (Fig. 13) parallels the reduction in IR-induced cell
death in theBECN1-haploinsufficient myocardium in vivo (5) and
compares favorably with effects of ROS scavenging in this setting
(48).
Maintenance of mitochondrial quality and mass is essential for
cell survival across multiple eukaryotic organisms (49–52), and
mitochondrial mass is tightly regulated to ensure efficient energy
generation in the mammalian heart (43). In the context of the
emerging evidence for a critical role of TFEB and its Candida
elegans orthologue hlh-30 in regulating mitochondrial mass
FIG 11 Hypoxia-reoxygenation/IR injury impairs TFEB activation. (A) Immunoblot depicting TFEB in NRCMs transduced with HA-TFEB (MOI 1; 24 h)
and subjected to hypoxia (1% ambient O2; 6 h) and then reoxygenation (18 h), followed by biochemical fractionation into cytoplasmic and nuclear fractions.
(B) Immunoblot depicting p-mTOR and total mTOR expression in NRCMs treated as described for panel A. (C) Transcript levels for representative autophagy-
lysosome machinery genes in NRCMs treated as described for panel A (n 9). (D and E) Transcript levels for autophagy-lysosome genes and unrelated ribosomal
genes in hearts subjected to in vivo IR injury (or sham procedure) and analyzed within the injured region (D) or the remote myocardium (E). (F to I)
Immunoblots and quantitation of endogenous beclin-1 abundances in hearts treated as described for panels D and E (n 4 for panels D to G).
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under starvation stress (25, 42, 47), our data suggest that sup-
pression of this evolutionarily conserved pathway may impair
mitochondrial quality control to limit myocardial salvage de-
spite expedient reperfusion in myocardial infarction. Specula-
tively, altered regulation of transcriptional repressors of the
autophagy-lysosome machinery (47, 53) may also contribute
to insufficient TFEB-activated transcription with IR injury and
requires further investigation.
Given that beclin-1 itself is a TFEB target (33), our findings
suggest that beclin-1 protein levels may be “sensed” via a counter-
regulatory loop to affect TFEB activity (Fig. 14) as a physiologic
mechanism to prime autophagy during starvation and to re-
plenish autophagy-lysosome proteins, including beclin-1,
which are consumed with a markedly upregulated autophagic
flux. In contrast, during IR injury, ROS-induced upregulation
of beclin-1 transcriptionally impairs autophagy by acting as a
counterregulatory brake to suppress TFEB activity, which im-
pairs removal of damaged mitochondria (6, 15) and prevents
restoration of normal mitochondria via PGC1 (Fig. 14). Un-
like the regulation of BECN1 in other cardiac disease states,
such as pressure overload (54), the rapid increase in beclin-1
with IR injury (5) and BNIP3 expression is posttranslational
(Fig. 2 and 12). Conceivably, ROS generation may oxidatively
modify the beclin-1 protein to prevent its degradation. Inter-
estingly, we observed a mobility shift in the beclin-1 protein
with BNIP3 expression (as also seen in LacZ-treated cells at the
48-h time point) (Fig. 2A), which may reflect the effects of
posttranslational modifications that need to be elucidated in
future studies. Prevalent beclin-1 levels affect mTOR activation
via its interaction with TSC1 (Fig. 6), and possibly through
TBC1D7 (TBC1 domain family member 7) (39), to regulate
TFEB activity (24). Alternatively, the beclin-1 protein has a
nuclear export signal (NES) motif which is masked in physio-
logic states but results in its nuclear accumulation with over-
expression (55), suggesting a potential for directly modulating
transcription. It is also pertinent that constitutive activation of
TFEB by chromosomal translocation is implicated in carcino-
genesis (56), whereby its counterregulation by beclin-1 may
mechanistically drive the observed tumorigenesis with BECN1
haploinsufficiency (26, 57).
In summary, we have uncovered a transcriptional regulatory
network that coordinately regulates lysosome biogenesis and mi-
FIG 12 BECN1 haploinsufficiency prevents IR-induced TFEB inactivation. (A and B) Immunoblot (A) and quantitation (B) of beclin-1 in IR-injured (or
sham-treated) myocardia from BECN1/ mice (n 4). (C and D) Immunoblot depicting myocardial TFEB (C) and quantitation of nuclear TFEB (D) in WT
and BECN1/ mice subjected to IR injury (or sham [Sh] procedure) followed by subcellular fractionation (n 3). White lines in panel C separate parts of the
same gel. (E to G) Immunoblot (E) and quantitation of LAMP1 (F) and LAMP2 (G) in IR-injured (or sham-treated) WT and BECN1/myocardia (n 4). (H
to J) Immunoblot (H) and quantitation of LC3-II (I) and p62 (J) in IR-injured (or sham-treated) WT and BECN1/ myocardia that were pretreated with CQ
or diluent to assess autophagic flux (n 3). (K to N) Immunoblots (K and M) and quantitation of PGC1 (L and N) in IR-injured (or sham-treated) WT (K and
L) and BECN1/ (M and N) myocardia (n 4).
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FIG 13 Partial beclin-1 knockdown restores mitochondrial quality in hypoxia-reoxygenation injury via the TFEB-PGC1 axis. (A and B) Representative flow cyto-
metric tracings (A) and quantitation (B) of LysoTracker fluorescence in NRCMs transduced with shBECN1-1, shBECN1-2, or shLacZ (MOI 1; 48 h) and subjected to
hypoxia-reoxygenation (6 h-18 h) or normoxia (24 h) (n 3). (C and D) Representative flow cytometric tracings of JC-1 fluorescence (C) and quantitation of cells with
predominantly depolarized mitochondria (D) in NRCMs transduced with shBECN1 constructs (or shLacZ), with or without shTFEB (or shLacZ) (MOI 1; 72 h), and
subjected to hypoxia (6 h) followed by reoxygenation (18 h) (n 4). (E) Cell death in NRCMs treated as described for panel C, with additional groups transduced with
a higher dose of shBECN1 constructs (MOI 10) (n 8 to 16). *, P 0.01 versus normoxia plus shLacZ (control); #, P 0.05 versus hypoxia-reoxygenation plus
shLacZ; $, P  0.05 versus respective shBECN1-treated group. (F) Cell death in NRCMs transduced with shBECN1-1 or shBECN1-2 (or shLacZ), with or without
shPPARGC1 or shLacZ (MOI 100; 72 h), and subjected to hypoxia-reoxygenation injury as described for panel A (n 14 to 16). (G and H) Cell death in NRCMs
transduced with PGC1 or TFEB and subjected to hypoxia-reoxygenation injury (n 8).
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tochondrial quality. Dysregulation of this network may be tar-
geted therapeutically to enhance mitochondrial preservation and
cellular preservation in myocardial infarction and ischemia-rep-
erfusion injury in other organ systems.
ACKNOWLEDGMENTS
We thank Junichi Sadoshima, UMDNJ, for providing Ad-shBECN1-1;
Brian Finck, Washington University, for expression vectors coding for
Renilla luciferase, TORC2, and constitutively active CREB; and Daniel P.
Kelly, Sanford-Burnham Medical Research Institute, for the human
PPARGC1 promoter-luciferase construct. We also thank Joan Avery and
YouJin Lee for technical assistance and Douglas L. Mann, Washington
University, for helpful comments and support.
This study was supported by grants from the NIH (HL107594) and the
Department of Veterans Affairs (I01BX000448 and 1I01BX001969)
to A.D.
X.M., H.L., S.R.F., R.J.G., J.T.M., and H.A. performed studies, ana-
lyzed data, and edited the manuscript. P.M.B. and A.D. designed and
supervised the work and wrote the manuscript. C.J.W. performed studies
and edited the manuscript.
We have no conflicts of interest to report.
REFERENCES
1. Leone TC, Kelly DP. 2011. Transcriptional control of cardiac fuel me-
tabolism and mitochondrial function. Cold Spring Harb Symp Quant Biol
76:175–182. http://dx.doi.org/10.1101/sqb.2011.76.011965.
2. Hausenloy DJ, Duchen MR, Yellon DM. 2003. Inhibiting mitochondrial
permeability transition pore opening at reperfusion protects against isch-
aemia-reperfusion injury. Cardiovasc Res 60:617– 625. http://dx.doi.org
/10.1016/j.cardiores.2003.09.025.
3. Carreira RS, Lee Y, Ghochani M, Gustafsson AB, Gottlieb RA. 2010.
Cyclophilin D is required for mitochondrial removal by autophagy in
cardiac cells. Autophagy 6:462– 472. http://dx.doi.org/10.4161/auto.6.4
.11553.
4. Kubli DA, Zhang X, Lee Y, Hanna RA, Quinsay MN, Nguyen CK,
Jimenez R, Petrosyan S, Murphy AN, Gustafsson AB. 2013. Parkin
protein deficiency exacerbates cardiac injury and reduces survival follow-
ing myocardial infarction. J Biol Chem 288:915–926. http://dx.doi.org/10
.1074/jbc.M112.411363.
5. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B,
Sadoshima J. 2007. Distinct roles of autophagy in the heart during isch-
emia and reperfusion: roles of AMP-activated protein kinase and Beclin 1
in mediating autophagy. Circ Res 100:914 –922. http://dx.doi.org/10.1161
/01.RES.0000261924.76669.36.
6. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, Diwan A.
2012. Impaired autophagosome clearance contributes to cardiomyocyte
death in ischemia/reperfusion injury. Circulation 125:3170 –3181. http:
//dx.doi.org/10.1161/CIRCULATIONAHA.111.041814.
7. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3
protein is induced by hypoxia. Proc Natl Acad Sci U S A 97:9082–9087.
http://dx.doi.org/10.1073/pnas.97.16.9082.
8. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. 2002. Hyp-
oxia and acidosis activate cardiac myocyte death through the Bcl-2 family
protein BNIP3. Proc Natl Acad Sci U S A 99:12825–12830. http://dx.doi
.org/10.1073/pnas.202474099.
9. Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, Saxena S, Gietz
RD, Greenberg AH. 1997. The E1B 19K/Bcl-2-binding protein Nip3 is a
dimeric mitochondrial protein that activates apoptosis. J Exp Med 186:
1975–1983. http://dx.doi.org/10.1084/jem.186.12.1975.
FIG 14 Schematic depicting the role of beclin-1 in mitochondrial quality control via the TFEB-PGC1 axis in IR injury. In IR or hypoxia-reoxygenation
injury, the reperfusion/reoxygenation-induced burst of ROS generation provokes mitochondrial permeabilization, leading to cell death (2). Transcrip-
tional induction of BNIP3 (4 h after induction of hypoxia [8]) further upregulates ROS generation from BNIP3-permeabilized mitochondria. While
mitochondrion-localized BNIP3 may act as an adaptor to facilitate autophagic removal of damaged mitochondria (13–15), we have found that autophagic
flux is impaired, resulting in accumulation of damaged mitochondria (6, 15). ROS provoke increased beclin-1 abundance, resulting in mTOR activation
and inhibition of TFEB, a master regulator of autophagy-lysosome machinery biogenesis. Beclin-1 itself is a TFEB target (33), which suggests a
counterregulatory loop whereby extant beclin-1 levels are sensed to regulate TFEB activation. Indeed, partial beclin-1 knockdown activates TFEB to
stimulate autophagic flux in these settings. TFEB coordinately drives mitochondrial biogenesis together with autophagic removal of damaged mitochon-
dria to restore normal mitochondria and prevent cell death. In IR injury, elevated beclin-1 levels result in suppression of the TFEB-PGC1 axis, which
triggers cardiomyocyte death.
Ma et al.
974 mcb.asm.org March 2015 Volume 35 Number 6Molecular and Cellular Biology
10. Kubli DA, Ycaza JE, Gustafsson AB. 2007. Bnip3 mediates mitochon-
drial dysfunction and cell death through Bax and Bak. Biochem J 405:407–
415. http://dx.doi.org/10.1042/BJ20070319.
11. Regula KM, Ens K, Kirshenbaum LA. 2002. Inducible expression of
BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death
of ventricular myocytes. Circ Res 91:226 –231. http://dx.doi.org/10.1161
/01.RES.0000029232.42227.16.
12. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirsh-
enbaum LA, Gottlieb RA, Gustafsson AB. 2007. Response to myocardial
ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death
Differ 14:146 –157. http://dx.doi.org/10.1038/sj.cdd.4401936.
13. Hamacher-Brady A, Brady NR, Gottlieb RA, Gustafsson AB. 2006.
Autophagy as a protective response to Bnip3-mediated apoptotic signal-
ing in the heart. Autophagy 2:307–309. http://dx.doi.org/10.4161/auto
.2947.
14. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB,
Gonzalez FJ, Semenza GL. 2008. Mitochondrial autophagy is an HIF-1-
dependent adaptive metabolic response to hypoxia. J Biol Chem 283:
10892–10903. http://dx.doi.org/10.1074/jbc.M800102200.
15. Ma X, Godar RJ, Liu H, Diwan A. 2012. Enhancing lysosome biogenesis
attenuates BNIP3-induced cardiomyocyte death. Autophagy 8:297–309.
http://dx.doi.org/10.4161/auto.18658.
16. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair
W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick
J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ. 2011. Phosphor-
ylation of ULK1 (hATG1) by AMP-activated protein kinase connects en-
ergy sensing to mitophagy. Science 331:456 – 461. http://dx.doi.org/10
.1126/science.1196371.
17. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M,
Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M,
Mizushima N, Otsu K. 2007. The role of autophagy in cardiomyocytes in
the basal state and in response to hemodynamic stress. Nat Med 13:619 –
624. http://dx.doi.org/10.1038/nm1574.
18. Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, Mi N, Zhao
Y, Liu Z, Wan F, Hailey DW, Oorschot V, Klumperman J, Baehrecke
EH, Lenardo MJ. 2010. Termination of autophagy and reformation of
lysosomes regulated by mTOR. Nature 465:942–946. http://dx.doi.org/10
.1038/nature09076.
19. Rong Y, McPhee CK, Deng S, Huang L, Chen L, Liu M, Tracy K,
Baehrecke EH, Yu L, Lenardo MJ. 2011. Spinster is required for au-
tophagic lysosome reformation and mTOR reactivation following starva-
tion. Proc Natl Acad Sci U S A 108:7826 –7831. http://dx.doi.org/10.1073
/pnas.1013800108.
20. Sridhar S, Patel B, Aphkhazava D, Macian F, Santambrogio L, Shields
D, Cuervo AM. 2013. The lipid kinase PI4KIIIbeta preserves lysosomal
identity. EMBO J 32:324 –339. http://dx.doi.org/10.1038/emboj.2012.341.
21. Martina JA, Chen Y, Gucek M, Puertollano R. 2012. MTORC1 functions
as a transcriptional regulator of autophagy by preventing nuclear
transport of TFEB. Autophagy 8:903–914. http://dx.doi.org/10.4161/auto
.19653.
22. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B,
Walther TC, Ferguson SM. 2012. The transcription factor TFEB links
mTORC1 signaling to transcriptional control of lysosome homeostasis.
Sci Signal 5:ra42. http://dx.doi.org/10.1126/scisignal.2002790.
23. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F,
Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M,
Rubinsztein DC, Ballabio A. 2011. TFEB links autophagy to lysosomal
biogenesis. Science 332:1429 –1433. http://dx.doi.org/10.1126/science
.1204592.
24. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh
T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini D,
Ballabio A. 2012. A lysosome-to-nucleus signalling mechanism senses
and regulates the lysosome via mTOR and TFEB. EMBO J 31:1095–1108.
http://dx.doi.org/10.1038/emboj.2012.32.
25. Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O,
Huynh T, Carissimo A, Palmer D, Klisch TJ, Wollenberg AC, Di
Bernardo D, Chan L, Irazoqui JE, Ballabio A. 2013. TFEB controls
cellular lipid metabolism through a starvation-induced autoregulatory
loop. Nat Cell Biol 15:647– 658. http://dx.doi.org/10.1038/ncb2718.
26. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J,
Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B. 2003.
Promotion of tumorigenesis by heterozygous disruption of the beclin 1
autophagy gene. J Clin Invest 112:1809 –1820. http://dx.doi.org/10.1172
/JCI20039.
27. Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN, Kim L,
Gottlieb RA. 2008. A method to measure cardiac autophagic flux in vivo.
Autophagy 4:322–329. http://dx.doi.org/10.4161/auto.5603.
28. Rikka S, Quinsay MN, Thomas RL, Kubli DA, Zhang X, Murphy AN,
Gustafsson AB. 2011. Bnip3 impairs mitochondrial bioenergetics and
stimulates mitochondrial turnover. Cell Death Differ 18:721–731. http:
//dx.doi.org/10.1038/cdd.2010.146.
29. Pagel-Langenickel I, Bao J, Joseph JJ, Schwartz DR, Mantell BS, Xu X,
Raghavachari N, Sack MN. 2008. PGC-1alpha integrates insulin signal-
ing, mitochondrial regulation, and bioenergetic function in skeletal
muscle. J Biol Chem 283:22464 –22472. http://dx.doi.org/10.1074/jbc
.M800842200.
30. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G,
Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney
JT, Corkey BE, Shirihai OS. 2008. Fission and selective fusion govern
mitochondrial segregation and elimination by autophagy. EMBO J 27:
433– 446. http://dx.doi.org/10.1038/sj.emboj.7601963.
31. Chambers KT, Leone TC, Sambandam N, Kovacs A, Wagg CS, Lopas-
chuk GD, Finck BN, Kelly DP. 2011. Chronic inhibition of pyruvate
dehydrogenase in heart triggers an adaptive metabolic response. J Biol
Chem 286:11155–11162. http://dx.doi.org/10.1074/jbc.M110.217349.
32. Hu J, Zacharek S, He YJ, Lee H, Shumway S, Duronio RJ, Xiong Y.
2008. WD40 protein FBW5 promotes ubiquitination of tumor suppressor
TSC2 by DDB1-CUL4-ROC1 ligase. Genes Dev 22:866 – 871. http://dx.doi
.org/10.1101/gad.1624008.
33. Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Ballabio
A. 2011. Characterization of the CLEAR network reveals an integrated
control of cellular clearance pathways. Hum Mol Genet 20:3852–3866.
http://dx.doi.org/10.1093/hmg/ddr306.
34. Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, Gonzales E, Burchett JM,
Schuler DR, Cirrito JR, Diwan A, Lee JM. 2014. Enhancing astrocytic
lysosome biogenesis facilitates A clearance and attenuates amyloid
plaque pathogenesis. J Neurosci 34:9607–9620. http://dx.doi.org/10.1523
/JNEUROSCI.3788-13.2014.
35. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Genna-
rino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S,
Parenti G, Cattaneo E, Ballabio A. 2009. A gene network regulating
lysosomal biogenesis and function. Science 325:473– 477. http://dx.doi
.org/10.1126/science.1174447.
36. Kiffin R, Christian C, Knecht E, Cuervo AM. 2004. Activation of chap-
erone-mediated autophagy during oxidative stress. Mol Biol Cell 15:
4829 – 4840. http://dx.doi.org/10.1091/mbc.E04-06-0477.
37. Wang L, Gout I, Proud CG. 2001. Cross-talk between the ERK and p70
S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2
in cardiomyocytes. J Biol Chem 276:32670 –32677. http://dx.doi.org/10
.1074/jbc.M102776200.
38. Martina JA, Puertollano R. 2013. Rag GTPases mediate amino acid-
dependent recruitment of TFEB and MITF to lysosomes. J Cell Biol 200:
475– 491. http://dx.doi.org/10.1083/jcb.201209135.
39. Behrends C, SowaME, Gygi SP, Harper JW. 2010. Network organization
of the human autophagy system. Nature 466:68 –76. http://dx.doi.org/10
.1038/nature09204.
40. Menon S, Dibble CC, Talbott G, Hoxhaj G, Valvezan AJ, Takahashi H,
Cantley LC, Manning BD. 2014. Spatial control of the TSC complex
integrates insulin and nutrient regulation of mTORC1 at the lysosome.
Cell 156:771–785. http://dx.doi.org/10.1016/j.cell.2013.11.049.
41. Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM,
Kwiatkowski DJ, Murphy LO, Manning BD. 2012. TBC1D7 is a third
subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47:
535–546. http://dx.doi.org/10.1016/j.molcel.2012.06.009.
42. Scott I, Webster BR, Chan CK, Okonkwo JU, Han K, Sack MN. 2014.
GCN5-like protein 1 (GCN5L1) controls mitochondrial content through
coordinated regulation of mitochondrial biogenesis and mitophagy. J Biol
Chem 289:2864 –2872. http://dx.doi.org/10.1074/jbc.M113.521641.
43. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP,
Medeiros DM, Kovacs A, Kelly DP. 2008. Transcriptional coactivators
PGC-1alpha and PGC-lbeta control overlapping programs required for
perinatal maturation of the heart. Genes Dev 22:1948 –1961. http://dx.doi
.org/10.1101/gad.1661708.
44. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D,
Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M. 2001.
Beclin-1 Regulates Mitochondrial Quality via TFEB
March 2015 Volume 35 Number 6 mcb.asm.org 975Molecular and Cellular Biology
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.
Nature 413:179 –183. http://dx.doi.org/10.1038/35093131.
45. Wu Z, Huang X, Feng Y, Handschin C, Feng Y, Gullicksen PS, Bare O,
Labow M, Spiegelman B, Stevenson SC. 2006. Transducer of regulated
CREB-binding proteins (TORCs) induce PGC-1alpha transcription and
mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci U S A 103:
14379 –14384. http://dx.doi.org/10.1073/pnas.0606714103.
46. Tan CY, Hagen T. 2013. Post-translational regulation of mTOR complex
1 in hypoxia and reoxygenation. Cell Signal 25:1235–1244. http://dx.doi
.org/10.1016/j.cellsig.2013.02.012.
47. O’Rourke EJ, Ruvkun G. 2013. MXL-3 and HLH-30 transcriptionally
link lipolysis and autophagy to nutrient availability. Nat Cell Biol 15:668 –
676. http://dx.doi.org/10.1038/ncb2741.
48. Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ,
Gorman JH, III, Sloan RC, Frasier CR, Watson CA, Bostian PA, Kypson
AP, Brown DA. 2012. Reduction of ischemia/reperfusion injury with
bendavia, a mitochondria-targeting cytoprotective peptide. J Am Heart
Assoc 1:e001644. http://dx.doi.org/10.1161/JAHA.112.001644.
49. Hughes AL, Gottschling DE. 2012. An early age increase in vacuolar pH
limits mitochondrial function and lifespan in yeast. Nature 492:261–265.
http://dx.doi.org/10.1038/nature11654.
50. Kurihara Y, Kanki T, Aoki Y, Hirota Y, Saigusa T, Uchiumi T, Kang D.
2012. Mitophagy plays an essential role in reducing mitochondrial pro-
duction of reactive oxygen species and mutation of mitochondrial DNA
by maintaining mitochondrial quantity and quality in yeast. J Biol Chem
287:3265–3272. http://dx.doi.org/10.1074/jbc.M111.280156.
51. Rafelski SM, Viana MP, Zhang Y, Chan YH, Thorn KS, Yam P, Fung
JC, Li H, Costa LF, Marshall WF. 2012. Mitochondrial network size
scaling in budding yeast. Science 338:822– 824. http://dx.doi.org/10.1126
/science.1225720.
52. Wu JJ, Quijano C, Chen E, Liu H, Cao L, Fergusson MM, Rovira II,
Gutkind S, Daniels MP, Komatsu M, Finkel T. 2009. Mitochondrial
dysfunction and oxidative stress mediate the physiological impairment
induced by the disruption of autophagy. Aging (Albany, NY) 1:425– 437.
53. Chauhan S, Goodwin JG, Chauhan S, Manyam G, Wang J, Kamat AM,
Boyd DD. 2013. ZKSCAN3 is a master transcriptional repressor of au-
tophagy. Mol Cell 50:16 –28. http://dx.doi.org/10.1016/j.molcel.2013.01
.024.
54. Pan W, Zhong Y, Cheng C, Liu B, Wang L, Li A, Xiong L, Liu S. 2013.
MiR-30-regulated autophagy mediates angiotensin II-induced myocar-
dial hypertrophy. PLoS One 8:e53950. http://dx.doi.org/10.1371/journal
.pone.0053950.
55. Liang XH, Yu J, Brown K, Levine B. 2001. Beclin 1 contains a leucine-
rich nuclear export signal that is required for its autophagy and tumor
suppressor function. Cancer Res 61:3443–3449.
56. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E,
Bridge J, Schuuring E, Schoenmakers EF, van Kessel AG. 2003. Upregu-
lation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal
cell carcinomas due to promoter substitution. Hum Mol Genet 12:1661–
1669. http://dx.doi.org/10.1093/hmg/ddg178.
57. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. 2003. Beclin 1, an autophagy
gene essential for early embryonic development, is a haploinsufficient tu-
mor suppressor. Proc Natl Acad Sci U S A 100:15077–15082. http://dx.doi
.org/10.1073/pnas.2436255100.
Ma et al.
976 mcb.asm.org March 2015 Volume 35 Number 6Molecular and Cellular Biology
